David Paton
Over 18 years of corporate advisory experience at Citibank, Macquarie Capital, Morgan Stanley and Shaw and Partners Extensive experience across M&A, ECM, DCM and business development / strategy execution
Andrew Fay
Andy has been a key driver in the corporate development team for nearly a decade High-level board experience across start-ups to large listed corporations has helped MicroBioGen negotiate several high-quality agreements
Dr Ivan Rajkovic
Ex-Partner at Shelston IP Significant IP expertise to ensure the break-throughs achieved are protected through an expanding patent portfolio
Dr Paul Attfield
One of MicroBioGen’s original principal scientists, focused on commercialisation activities With world-leading expertise in fermentation and biochemistry
Dr Philip Bell
Leads the R&D team of 20 scientists on activities day-to-day, one of the principal scientists since MicroBioGen’s founding in 2001 Focused on driving innovation in the company through the highly trained research team
Jenny Hart
Manages all aspects of finance, HR and contracts at MicroBioGen Responsible for external stakeholder management Prior experience includes 23 years of commercial management at AGL Energy
Geoff Bell
Facilitated MicroBioGen’s transformation from pure research group into international commercial success Prior experience includes over 15 years at two global investment banks in equity research and top-rated research analyst